Aix en Provence -- Under a public program from the Russian Ministry of Health (MOH), twenty-six hospitals throughout the Russian Federation acquired SuperSonic Imagine's Aixplorer MultiWave™ Ultrasound System. The Aixplorer, with MultiWave Technology is considered the most technologically advanced system available on the market.

This public program titled: "Viral Hepatitis" is part of a National Project, financed by the Russian Ministry of Health and started in 2007, named "Prevention and Struggle with Socially Significant Diseases".

Heinemann Medizintechnik in Moscow, the exclusive distribution partner for SuperSonic Imagine for the Russian Federation, was awarded this pubic tender for the Aixplorer systems at the end of 2010.
Twenty-six hospitals across the Federation from Sakhalin to Murmansk city were equipped with the Aixplorer because of its exceptional B-mode image quality and its unique technology, ShearWave Elastography, where tissue stiffness can be measured in kilopascals* in a user-skill independent and reproducible manner. Tissue stiffness is an additional parameter that characterizes tissue and can be a valuable indicator of pathology. The Aixplorer, which has a worldwide installed base, brings clinicians significantly enhanced diagnostic information.

About SuperSonic Imagine:

Founded in 2005 and based in Aix-en-Provence, France, SuperSonic Imagine is an innovative, multinational medical imaging company dedicated to developing a revolutionary ultrasound system: the Aixplorer®. This system leverages a unique MultiWave technology that enables the user to detect, characterize and, in the future, treat palpable and non-palpable masses. MultiWave technology is based on combining two types of waves: an ultrasound wave that provides exceptional imaging in B-mode, and a shear wave, ShearWave Elastography, which measures and displays the stiffness of tissue in kilopascals*. ShearWave Elastography is user-skill independent with reproducible results. Aixplorer is CE mark approved since 2008 and has FDA clearance since 2009 and has several clinical applications: breast (and 3D breast), thyroid, abdomen, liver, musculo-skeletal, prostate, and gynaecological (excluding obstetrics).

SuperSonic Imagine has both a direct sales and distribution network worldwide, including Hologic Inc. (Nasdaq: HOLX) for the breast care market in the USA and Canon Marketing in Japan. SuperSonic Imagine holds the exclusive right, title and interest to 25 international patents and submissions in diagnostic imaging and therapy applications. Company investors include Edmond de Rothschild Investment Partners (EdRIP), Auriga Partners, Crédit Agricole Private Equity (CAPE), NBGI Ventures, Bioam, Mérieux Développement, Wellington Partners, Innobio, Canon (NYSE:CAJ), and IXO Private Equity.

For further information about SuperSonic Imagine please visit our website:
www.supersonicimagine.com
http://www.supersonicimagine.fr
http://www.youtube.com/watch?v=oF9xZPZai_s

* Quantification available outside USA.

More HCB News